Medacta Group Sa Stock Total Asset
| MOVE Stock | 111.40 0.80 0.72% |
Medacta Group SA fundamentals help investors to digest information that contributes to Medacta Group's financial success or failures. It also enables traders to predict the movement of Medacta Stock. The fundamental analysis module provides a way to measure Medacta Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medacta Group stock.
Medacta |
Medacta Group SA Company Total Asset Analysis
Medacta Group's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Medacta Group Total Asset | 489.27 M |
Most of Medacta Group's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medacta Group SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, Medacta Group SA has a Total Asset of 489.27 M. This is 93.49% lower than that of the Healthcare sector and 92.26% lower than that of the Medical Devices industry. The total asset for all Switzerland stocks is 98.34% higher than that of the company.
Medacta Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medacta Group's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medacta Group could also be used in its relative valuation, which is a method of valuing Medacta Group by comparing valuation metrics of similar companies.Medacta Group is currently under evaluation in total asset category among related companies.
Medacta Fundamentals
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0752 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 1.98 B | |||
| Shares Outstanding | 19.98 M | |||
| Shares Owned By Insiders | 69.53 % | |||
| Shares Owned By Institutions | 17.99 % | |||
| Price To Book | 7.98 X | |||
| Price To Sales | 4.85 X | |||
| Revenue | 363.13 M | |||
| Gross Profit | 261.25 M | |||
| EBITDA | 99.33 M | |||
| Net Income | 51.52 M | |||
| Total Debt | 63.17 M | |||
| Book Value Per Share | 12.62 X | |||
| Cash Flow From Operations | 54.06 M | |||
| Earnings Per Share | 2.38 X | |||
| Target Price | 109.63 | |||
| Number Of Employees | 1.42 K | |||
| Beta | 1.12 | |||
| Market Capitalization | 2.08 B | |||
| Total Asset | 489.27 M | |||
| Z Score | 19.2 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 489.27 M | |||
| Last Dividend Paid | 0.54 |
About Medacta Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medacta Group SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medacta Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medacta Group SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medacta Group SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Medacta Stock analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |